Microbiome-host interactions in oral squamous cell carcinoma: a meta-transcriptomic exploratory study

口腔鳞状细胞癌中微生物组与宿主的相互作用:一项宏转录组学探索性研究

基本信息

  • 批准号:
    9809205
  • 负责人:
  • 金额:
    $ 19.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

Project summary Oral cancer (predominantly squamous cell carcinoma; OSCC) is the 14th most prevalent malignancy worldwide accounting for more than 300,000 new cases and 145,000 deaths annually. Despite advances in cancer treatment modalities, OSCC continues to have poor prognosis with 5-year survival rates less than 50%. Although use of tobacco and alcohol consumption constitute the major risk factors, there is emerging evidence for the role of microbiome in OSCC. Exploration of such a role has been facilitated by the advent of next generation sequencing and availability of big data analysis tools. However, studies on the association between the microbiome and OSCC has so far focused on compositional analysis, and has been largely limited to the bacterial component of the microbiome. Furthermore, the results from these studies have not been consistent. Our preliminary work demonstrates presence of complex community of microbes other than bacteria including fungi, archaea, viruses and even protists. In addition, it shows that functional analysis generates results that are more consistent, and more importantly, that are directly relevant to the carcinogenic process. In this study, we propose to use RNA sequencing coupled with comprehensive bioinformatic analysis to study the metatranscriptome of OSCC tissues. Specifically, the study will characterize the transcriptional activity (function) as well as composition of the multi-kingdom microbiome associated with OSCC (aim 1), and correlate it with the gene expression of the host (aim 2). The study will provide a new insight into the role microbiome in OSCC by providing preliminary data on the possible mechanisms by which the tumor's microbial community may influence on its behavior.
项目摘要 口腔癌(主要是鳞状细胞癌; OSCC)是第14位最常见的恶性肿瘤 在世界范围内,每年有超过30万例新病例和14.5万例死亡。尽管取得了进展 在癌症治疗方式中,OSCC的预后仍然很差,5年生存率低于 超过50%。虽然吸烟和饮酒是主要的危险因素, 微生物组在口腔鳞状细胞癌中作用的新证据。对这一作用的探索得到了以下方面的推动: 下一代测序的出现和大数据分析工具的可用性。然而,关于 微生物组和口腔鳞状细胞癌之间的联系迄今为止集中在成分分析上, 主要局限于微生物组的细菌成分。此外,来自 这些研究并不一致。我们的初步工作表明, 除细菌外的微生物群落,包括真菌、古细菌、病毒甚至原生生物。在 此外,它还表明,功能分析产生的结果更加一致, 重要的是,这些都与致癌过程直接相关。在这项研究中,我们建议使用RNA 测序结合综合生物信息学分析研究口腔鳞癌的元转录组 组织中具体而言,该研究将表征转录活性(功能)以及 与OSCC相关的多王国微生物组的组成(目的1),并将其与 宿主的基因表达(目的2)。这项研究将为微生物组在疾病中的作用提供新的见解。 通过提供有关肿瘤微生物作用可能机制的初步数据来研究OSCC 社区可能会影响其行为。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nezar Al-Hebshi其他文献

Nezar Al-Hebshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nezar Al-Hebshi', 18)}}的其他基金

The microbiome associated with oral Leukoplakia: A multi-omics mechanistic study
与口腔白斑相关的微生物组:一项多组学机制研究
  • 批准号:
    10870268
  • 财政年份:
    2023
  • 资助金额:
    $ 19.64万
  • 项目类别:
In vitro reproducible model of subgingival microbiome for high throughput screening for microbiome modulators
用于微生物组调节剂高通量筛选的龈下微生物组体外可重复模型
  • 批准号:
    9973103
  • 财政年份:
    2019
  • 资助金额:
    $ 19.64万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.64万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了